Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
- Dreyling M, Santoro A, Mollica L, et al. Copanlisib in patients with relapsed or refractory indolent B-cell lymphoma: Primary results of the pivotal Chronos-1 study. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2017, April 5-7, Washington, DC. Cancer Res. 2017; 77(13 Suppl). Abstract CT149.